Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nohara
    Junior Member
    • Apr 2012
    • 1

    RNase treat gDNA?

    Hi all,
    I am preparing gDNA for Illumina sequening (short reads and paired-end). I will be quantifying the sample using qPCR. I am wondering why RNase treatment is recommended in some sample protocols and if I really need to do it. Could it potentially interfere with quantification by the genomics facility where I am sequencing? I would prefer not to RNase treat as I have limited DNA and I don't want to mess with it too much. DNA was extracted using a Qiagen kit and looks pretty pure. Could small amounts of RNA disrupt the library preparation process or the quantification process when I send the samples in for library prep?
    Any help would be appreciated!
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    Originally posted by nohara View Post
    Hi all,
    I am preparing gDNA for Illumina sequening (short reads and paired-end). I will be quantifying the sample using qPCR. I am wondering why RNase treatment is recommended in some sample protocols and if I really need to do it. Could it potentially interfere with quantification by the genomics facility where I am sequencing? I would prefer not to RNase treat as I have limited DNA and I don't want to mess with it too much. DNA was extracted using a Qiagen kit and looks pretty pure. Could small amounts of RNA disrupt the library preparation process or the quantification process when I send the samples in for library prep?
    Any help would be appreciated!
    A typical genomic DNA prep is >90% RNA. Qiagen can do better than that, but probably does have a good deal of RNA in it. So, the first problem with RNA is that it throws off UV spectrometric estimates of the concentration of RNA. But if you are using some other method (agarose gel or fluorimetry) then RNA is not a quantification issue.

    Second, will T4 DNA ligase ligate extraneous RNA to your DNA adapters? If it can, then you want to reduce the amount of RNA in your sample as much as possible to get optimum results. A decade ago I would have said "no way". But now I am less certain. There is an excellent paper on the topic: Bullard DR, Bowater RP (2006) Direct comparison of nick-joining activity of the nucleic acid ligases from bacteriophage T4. Biochemical Journal 398: 135-144

    I thought I had posted in detail about this before. But google is showing me little. So I whipped up a post and put it here.

    Anyway, to a first approximation, a little RNA is unlikely to cause problems, but with DNA preps there is often quite a bit more than "a little" RNA present.

    --
    Phillip

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...